{"id":4480,"date":"2020-03-25T11:05:48","date_gmt":"2020-03-25T11:05:48","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=4480"},"modified":"2020-03-25T11:05:48","modified_gmt":"2020-03-25T11:05:48","slug":"changing-the-lives-of-patients-living-with-a-narrowed-aortic-valve","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/changing-the-lives-of-patients-living-with-a-narrowed-aortic-valve\/4480\/","title":{"rendered":"Changing the lives of patients living with a narrowed aortic valve"},"content":{"rendered":"
Mainz University Medical Center<\/a> have recently launched a new treatment for patients with a narrowed aortic valve. For the first time in Europe, cardiologists have implanted a new motor-driven, self-expanding heart valve, increasing safety while reducing leakage.<\/p>\n There has been a rise in the number of people in Germany suffering from a symptomatic constriction of the aortic valve<\/a>, which is the most common heart valve defect in elderly patients. The standard therapy for this defect has been a cardiac-surgical valve replacement.<\/p>\n In the last five years the number of catheter-assisted aortic valve replacement therapy (TAVI) has increased greatly. In 2018, there were nearly 20,000 medical interventions of this kind in Germany.<\/p>\n The Department of Cardiology of the Mainz University Medical Center occupies a leading position in the field of minimally invasive heart valve therapy<\/a>, conducting more than 700 interventions per year, with approximately 400 TAVI procedures were carried out here last year.<\/p>\n Cardiologists have now reported the first implantation of the latest model of a self-expanding aortic valve (CENTERA\u00ae) in Mainz.<\/p>\nThe advantages of this new technology<\/h3>\n